Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study

BMC Infectious Diseases

Yazdan Yazdanpanah¹  Caroline Semaille⁸  Marcel Calvez⁵  Pascal Béchu²  Olivier Patey⁶  Karine Lacombe⁹  Emilie Lanoy³  Sylvie Deuffic-Burban⁷  Stéphane Le Vu⁸  Lise Cuzin⁴  Anthony Cousien⁷  Karen Champenois⁷ 

[1] Université Denis Diderot, Paris, France;CHRU de Lille, Lille, France;Institut Gustave Roussy, Service de Biostatistique et Epidémiologie, Villejuif, France;Service des Maladies Infectieuses, CHU de Toulouse, Toulouse, France;CNRS UMR6590, Rennes, France;Service des Maladies Infectieuses et Tropicales, CHI Villeneuve-Saint-Georges, Villeneuve-Saint-Georges, France;Université Lille Nord de France, Lille EA2694, France;Institut de Veille Sanitaire, Saint-Maurice, France;Université Pierre et Marie Curie, Paris, France

关键词: Access to care;    Risk assessment;    Late diagnosis;    HIV testing;    HIV/AIDS;   

Others  :  1148614
DOI  :  10.1186/1471-2334-13-200

 received in 2012-10-31, accepted in 2013-04-19,  发布年份 2013

【 摘 要 】

Background

In France, 1/3 HIV-infected patients is diagnosed at an advanced stage of the disease. We describe missed opportunities for earlier HIV testing in newly-HIV-diagnosed patients.

Methods

Cross sectional study. Adults living in France for ≥1 year, diagnosed with HIV-infection ≤6 months earlier, were included from 06/2009 to 10/2010. We collected information on patient characteristics at diagnosis, history of HIV testing, contacts with healthcare settings, and occurrence of HIV-related events 3 years prior to HIV diagnosis. During these 3 years, we assessed whether or not HIV testing had been proposed by the healthcare provider upon first contact in patients notifying that they were MSM or had HIV-related conditions.

Results

1,008 newly HIV-diagnosed patients (mean age: 39 years; male: 79%; MSM: 53%; diagnosed with an AIDS-defining event: 16%). During the 3-year period prior to HIV diagnosis, 99% of participants had frequented a healthcare setting and 89% had seen a general practitioner at least once a year. During a contact with a healthcare setting, 91/191 MSM (48%) with no HIV-related conditions, said being MSM; 50 of these (55%) did not have any HIV test proposal. Only 21% (41/191) of overall MSM who visited a healthcare provider received a test proposal. Likewise, 299/364 patients (82%) who sought care for s had a missed opportunity for HIV testing.

Conclusions

Under current screening policies, missed opportunities for HIV testing remain unacceptably high. This argues in favor of improving risk assessment, and HIV-related conditions recognition in all healthcare facilities.

【 授权许可】

   
2013 Champenois et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Mocroft A, Sabin CA, Youle M, Madge S, Tyrer M, Devereux H: Changes in AIDS-defining illnesses in a London Clinic, 1987–1998. J Acquir Immune Defic Syndr 1999, 21:401-407.
• [2]Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
• [3]Keiser O, Taffe P, Zwahlen M, Battegay M, Bernasconi E, Weber R: All cause mortality in the Swiss HIV Cohort Study from 1990 to 2001 in comparison with the Swiss population. AIDS 2004, 18:1835-1843.
• [4]Holmberg SD, Palella FJ Jr, Lichtenstein KA, Havlir DV: The case for earlier treatment of HIV infection. Clin Infect Dis 2004, 39:1699-1704.
• [5]Bhaskaran K, Hamouda O, Sannes M, Boufassa F, Johnson AM, Lambert PC: Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA 2008, 300:51-59.
• [6]Attia S, Egger M, Muller M, Zwahlen M, Low N: Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 2009, 23:1397-1404.
• [7]Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N: Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011, 365:493-505.
• [8]Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L: When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med 2011, 154:509-515.
• [9]Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. 2011. Available at http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf webcite ; accessed date: April 2013.
• [10]Yéni P: Rapport 2010. Prise en charge médicale des personnes infectées par le VIH. Recommendations du groupe d’experts. Paris: Médecine-Sciences. Flammarion; 2010.
• [11]Hamers FF, Phillips AN: Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med 2008, 9(Suppl 2):6-12.
• [12]Borghi V, Girardi E, Bellelli S, Angeletti C, Mussini C, Porter K: Late presenters in an HIV surveillance system in Italy during the period 1992–2006. J Acquir Immune Defic Syndr 2008, 49:282-286.
• [13]Girardi E, Sabin CA, Monforte AD: Late diagnosis of HIV infection: epidemiological features, consequences and strategies to encourage earlier testing. J Acquir Immune Defic Syndr 2007, 46(Suppl 1):S3-S8.
• [14]Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C: Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther 2007, 12:89-96.
• [15]Manavi K, McMillan A, Ogilvie M, Scott G: Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. Int J STD AIDS 2004, 15:811-814.
• [16]Sabin CA, Schwenk A, Johnson MA, Gazzard B, Fisher M, Walsh J: Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS 2010, 24:723-727.
• [17]Sullivan AK, Curtis H, Sabin CA, Johnson MA: Newly diagnosed HIV infections: review in UK and Ireland. BMJ 2005, 330:1301-1302.
• [18]Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R: Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. HIV Med 2008, 9:397-405.
• [19]Cazein F, Le Strat Y, Pillonel J, Lot F, Bousquet V, Pinget R: HIV testing and new HIV diagnoses, France, 2003–2010. Bulletin épidémiologique hebdomadaire 2011, 43–44:446-454.
• [20]Burke RC, Sepkowitz KA, Bernstein KT, Karpati AM, Myers JE, Tsoi BW: Why don’t physicians test for HIV? A review of the US literature. AIDS 2007, 21:1617-1624.
• [21]Deblonde J, De Koker P, Hamers FF, Fontaine J, Luchters S, Temmerman M: Barriers to HIV testing in Europe: a systematic review. Eur J Public Health 2010, 20:422-432.
• [22]Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ: Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings. Sex Transm Dis 2006, 33:329-333.
• [23]Kellerman SE, Lehman JS, Lansky A, Stevens MR, Hecht FM, Bindman AB: HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr 2002, 31:202-210.
• [24]Mounier-Jack S, Nielsen S, Coker RJ: HIV testing strategies across European countries. HIV Med 2008, 9(Suppl 2):13-19.
• [25]Advancing HIV: prevention: new strategies for a changing epidemic–United States, 2003. MMWR Morb Mortal Wkly Rep 2003, 52:329-332.
• [26]Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB: Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006, 55:1-17. quiz CE11-14
• [27]British HIV Association: UK National Guidelines for HIV Testing 2008. 2008. available at http://www.bhiva.org/documents/Guidelines/Testing/GlinesHIVTest08.pdf webcite; accessed date: April 2013.
• [28]Haute Autorité de Santé. Recommandations en santé publique - Dépistage de l’infection par le VIH en France - Stratégies et dispositif de dépistage: Haute Autorité de Santé. Recommandations en santé publique - Dépistage de l’infection par le VIH en France - Stratégies et dispositif de dépistage. 2009. Available at http://www.has-sante.fr/portail/jcms/c_704257/depistage-de-linfection-par-le-vih-en-france-modalites-de-realisation-des-tests-de-depistage webcite (Accessed Feb 2013)
• [29]Yazdanpanah Y, Sloan CE, Charlois-Ou C, Le Vu S, Semaille C, Costagliola D: Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One 2010, 5:e13132.
• [30]Communication à la commission des affaires sociales de l’Assemblée nationale. La prévention sanitaire. 2011. Available at http://www.assemblee-nationale.fr/13/budget/mecss/Communication_CDC_prevention_sanitaire.pdf webcite (Accessed Feb. 2013)
• [31]Haukoos JS, Hopkins E, Byyny RL, Conroy AA, Silverman M, Eisert S: Design and implementation of a controlled clinical trial to evaluate the effectiveness and efficiency of routine opt-out rapid human immunodeficiency virus screening in the emergency department. Acad Emerg Med 2009, 16:800-808.
• [32]Haukoos JS, Hopkins E, Conroy AA, Silverman M, Byyny RL, Eisert S: Routine opt-out rapid HIV screening and detection of HIV infection in emergency department patients. JAMA 2010, 304:284-292.
• [33]CDC: Missed opportunities for earlier diagnosis of HIV infection--South Carolina, 1997–2005. MMWR Morb Mortal Wkly Rep 2006, 55:1269-1272.
• [34]Klein D, Hurley LB, Merrill D, Quesenberry CP Jr: Review of medical encounters in the 5 years before a diagnosis of HIV-1 infection: implications for early detection. J Acquir Immune Defic Syndr 2003, 32:143-152.
• [35]Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH: Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med 2004, 19:349-356.
• [36]McDonald EA, Currie MJ, Bowden FJ: Delayed diagnosis of HIV: missed opportunities and triggers for testing in the Australian Capital Territory. Sex Health 2006, 3:291-295.
• [37]Freedberg KA, Samet JH: Think HIV: why physicians should lower their threshold for HIV testing. Arch Intern Med 1999, 159:1994-2000.
• [38]Girard P, Katlama C, Pialoux G: VIH. 7th edition. Rueil Malmaison: Doin; 2007.
• [39]Klein D, Hurley LB, Merrill D, Suh C, Young T: Early Detection of HIV: The HEDS UP Study. Chicago, IL: 8th Conference on Retoviruses and Opportunistic Infections; 2001:219.
• [40]Copenhagen HIV Programme: HIV Indicator conditions: Guidance for Implementing HIV Testing in Adults in Health Care Settings. 2012. Available at http://www.hiveurope.eu/GuidanceHIVIndicatorConditions/tabid/176/Default.aspx webcite (Accessed Feb. 2013)
• [41]Troude P, Chaix ML, Tran L, Deveau C, Seng R, Delfraissy JF: No evidence of a change in HIV-1 virulence since 1996 in France. AIDS 2009, 23:1261-1267.
• [42]Cazein F, Lot F, Pillonel J, Pinget R, Bousquet V, Le Strat Y: Surveillance of HIV/AIDS infection in France, 2009. Bulletin Epidémiologique Hebdomadaire 2010, 45–46:467-472.
• [43]Lyons MS, Lindsell CJ, Ledyard HK, Frame PT, Trott AT: Emergency department HIV testing and counseling: an ongoing experience in a low-prevalence area. Ann Emerg Med 2005, 46:22-28.
• [44]Burns FM, Johnson AM, Nazroo J, Ainsworth J, Anderson J, Fakoya A: Missed opportunities for earlier HIV diagnosis within primary and secondary healthcare settings in the UK. AIDS 2008, 22:115-122.
• [45]Spire B, de Zoysa I, Himmich H: HIV prevention: What have we learned from community experiences in concentrated epidemics? J Int AIDS Soc 2008, 11:5. BioMed Central Full Text
• [46]Epstein RM, Morse DS, Frankel RM, Frarey L, Anderson K, Beckman HB: Awkward moments in patient-physician communication about HIV risk. Ann Intern Med 1998, 128:435-442.
• [47]Petroll AE, Mosack KE: Physician awareness of sexual orientation and preventive health recommendations to men who have sex with men. Sex Transm Dis 2011, 38:63-67.
• [48]D’Almeida KW, Kierzek G, de Truchis P, Le Vu S, Pateron D, Renaud B: Modest Public Health Impact of Nontargeted Human Immunodeficiency Virus Screening in 29 Emergency Departments. Arch Intern Med 2011, 172(1):12-20.
• [49]Haukoos JS, Hopkins E, Bender B, Sasson C, Al-Tayyib AA, Thrun MW: Comparison of Enhanced Targeted Rapid HIV Screening Using the Denver HIV Risk Score to Nontargeted Rapid HIV Screening in the Emergency Department. Ann Emerg Med 2013, 61:353-361.
• [50]Sullivan AK, Raben D, Reekie J, Rayment M, Mocroft A, Esser S: Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study). PLoS One 2013, 8:e52845.